FMS:NYE-Fresenius Medical Care AG (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 23.22

Change

-0.38 (-1.61)%

Market Cap

USD 23.44B

Volume

0.19M

Analyst Target

USD 44.77
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+0.94 (+0.29%)

USD 81.54B
THC Tenet Healthcare Corporation

+1.59 (+1.17%)

USD 13.36B
DVA DaVita HealthCare Partners Inc

-9.04 (-5.83%)

USD 12.59B
UHS Universal Health Services Inc

+0.75 (+0.41%)

USD 12.40B
EHC Encompass Health Corp

-1.69 (-1.66%)

USD 10.06B
CHE Chemed Corp

-5.54 (-1.00%)

USD 8.24B
CON Concentra Group Holdings Paren..

+0.06 (+0.26%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.28 (+1.92%)

USD 2.59B
NHC National HealthCare Corporatio..

-4.49 (-4.45%)

USD 1.90B
AGL agilon health Inc

+0.05 (+1.40%)

USD 1.41B

ETFs Containing FMS

UTES Virtus Reaves Utilities E.. 4.66 % 0.95 %

-1.03 (-0.73%)

USD 0.42B
TPYP Tortoise North American P.. 4.09 % 0.40 %

+0.05 (+-0.73%)

N/A
SMIG ETF Series Solutions - AA.. 3.78 % 0.00 %

-0.22 (-0.73%)

USD 0.84B
RYU 3.37 % 0.40 %

N/A

N/A
TPHE Timothy Plan - Timothy Pl.. 1.73 % 0.00 %

-0.01 (-0.73%)

USD 0.06B
TPHD Timothy Plan High Dividen.. 1.72 % 0.00 %

-0.02 (-0.73%)

USD 0.24B
CDC VictoryShares US EQ Incom.. 1.58 % 0.35 %

N/A

USD 0.78B
ULVM VictoryShares US Value Mo.. 1.42 % 0.20 %

-0.62 (-0.73%)

USD 0.16B
DON WisdomTree U.S. MidCap Di.. 0.82 % 0.38 %

-0.23 (-0.73%)

N/A
TPLE Timothy Plan - Timothy Pl.. 0.69 % 0.00 %

-0.13 (-0.73%)

USD 0.07B
TPLC Timothy Plan US Large/Mid.. 0.68 % 0.00 %

-0.19 (-0.73%)

USD 0.26B
BKMC BNY Mellon US Mid Cap Cor.. 0.53 % 0.00 %

-0.94 (-0.73%)

USD 0.55B
FVD First Trust Value Line® .. 0.50 % 0.70 %

+0.10 (+-0.73%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.56% 43% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.56% 43% F 49% F
Trailing 12 Months  
Capital Gain 20.19% 65% D 75% C
Dividend Return 3.28% 80% B- 50% F
Total Return 23.47% 65% D 76% C+
Trailing 5 Years  
Capital Gain -43.38% 22% F 12% F
Dividend Return 8.54% 88% B+ 25% F
Total Return -34.84% 22% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -12.96% 13% F 4% F
Dividend Return -10.46% 13% F 5% F
Total Return 2.51% 90% A- 56% F
Risk Return Profile  
Volatility (Standard Deviation) 26.88% 87% B+ 40% F
Risk Adjusted Return -38.89% 13% F 6% D-
Market Capitalization 23.44B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.30 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector